Linked Life Data

12804472

Source:http://linkedlifedata.com/resource/pubmed/id/12804472

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-6-13
pubmed:abstractText
The prevention and early treatment of infections are the mainstay of the medical management of the majority of children with HIV infection, who live in low income countries without access to antiretroviral drugs. Cotrimoxazole is cheap and effective against a wide range of organisms, including Pneumocystis carinii pneumonia (PCP) which is an important cause of death and illness in the first year of life. It is safe with relatively few side-effects. Diagnosis of HIV in children is complicated by the presence of maternal antibodies in early life and providing prophylaxis based initially on maternal status is one possible solution. However routine prophylactic treatment is difficult to deliver in low-resource settings, and could also lead to increased resistance to the drug.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD003508
pubmed:dateRevised
2006-4-7
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
pubmed:affiliation
Hlabisa Hospital, Private Bag X5001, Hlabisa, Hlabisa, South Africa. kcg@iafrica.com
pubmed:publicationType
Journal Article, Review